Geftinat 250mg Gefitinib Tablets IP

Geftinat 250mg Gefitinib Tablets IP Specification

Indication
Non-Small Cell Lung Cancer (NSCLC)

Salt Composition
Gefitinib IP 250mg

Dosage Form
Tablet

Feature
Film-coated tablet

Ingredients
Gefitinib

Application
Clinical

Physical Color/Texture
White to off-white tablet

Fermentation Smell
Odorless

Storage Instructions
Store below 30C, protect from light and moisture

Shelf Life
64 months

Pack Size
30 tablets

ATC Code
L01XE02

Dose/Strength
250 mg

Tablet Shape
Round

Storage Condition
Dry place

Route of Administration
Oral

Product Category
Anticancer

Manufactured By
Natco Pharma Ltd.

Prescription
Required

Packaging Type
Blister pack/striped

Geftinat 250mg Gefitinib Tablets IP Trade Information

Minimum Order Quantity
1 Strip

Supply Ability
5000 Strips Per Month

Delivery Time
10 Days

About Geftinat 250mg Gefitinib Tablets IP

Purchase the sought-after Geftinat 250mg Gefitinib Tablets IP, a top-drawer anticancer medication spotlit for its grand efficacy in treating Non-Small Cell Lung Cancer (NSCLC). With a dosage strength of 250 mg and oral administration, these prescription tablets are crafted by Natco Pharma Ltd., ensuring reliable quality. Each round, film-coated tablet is housed in a secure blister pack/strip, with a pack size of 30 tablets. Store in a dry place below 30C to maintain the product's integrity and potency over a generous 64-month shelf life. Exported, supplied, and traded from India, Geftinat offers trusted cancer care support.

Competitive Advantages and Special Features of Geftinat 250mg Gefitinib Tablets IP

Geftinat 250mg Gefitinib Tablets IP stands out due to its reliable oral delivery and grand efficacy in NSCLC management. Sought-after for its precise dosage and film-coated composition, it ensures optimal absorption and stability. The tablets are manufactured by Natco Pharma Ltd., renowned for top-drawer pharmaceuticals. Designed for clinical applications, their usage type extends from clinical trials to specialized cancer therapy. Each tablet is odorless, has a round shape, and is engineered for a long-lasting shelf life of 64 months.

Packaging Details, Sample Policy, and Sample Availability for Geftinat 250mg

Geftinat 250mg Gefitinib Tablets are carefully packed in blister strips, maintaining the market value and product integrity during transported or shipped goods. Quotations are readily available upon request for bulk orders. Exporters, suppliers, traders, and wholesalers from India ensure seamless global distribution. Samples are available upon qualified request, helping buyers assess product quality before placing large orders. Each package includes 30 white to off-white, film-coated tablets, safeguarded per recommended storage instructions for optimal shelf stability.

FAQ's of Geftinat 250mg Gefitinib Tablets IP:

Q: How should Geftinat 250mg Gefitinib Tablets be stored?

A: Geftinat 250mg tablets should be kept in a dry place, at temperatures below 30C. Avoid exposure to light and moisture to preserve their integrity throughout the 64-month shelf life.

Q: What is the main usage of Geftinat 250mg Gefitinib Tablets?

A: The primary use of Geftinat 250mg is to treat patients with Non-Small Cell Lung Cancer (NSCLC). It is administered orally as per the healthcare provider's prescription.

Q: When can a sample of Geftinat 250mg Gefitinib Tablets be requested?

A: Samples of Geftinat 250mg are available to buyers upon qualified request, typically when considering bulk or large orders, to allow market evaluation and ensure customer satisfaction.

Q: Where is Geftinat 250mg Gefitinib Tablets manufactured and supplied from?

A: Geftinat 250mg is manufactured by Natco Pharma Ltd. in India and is distributed globally by exporters, suppliers, traders, and wholesalers based in India.

Q: What competitive advantage does Geftinat 250mg offer in the market?

A: Geftinat 250mg is highlighted for its film-coated formulation, grand shelf life, reliable clinical performance, and is produced by a top-drawer manufacturer, making it a sought-after anticancer therapy worldwide.

Tell us about your requirement